Lecture: Immune responses to HCV

This lecture was about understanding the role of interferon stimulated gene (ISG) expression and the relationship to nHCV infection.  We all have some degree of ISG expression; this is partly responsible for combating the virus.  As you can see from the graphic above, these genes are upregulated by activation of the Jak/STAT pathway, among others.  This is the pathway that HCV tries to disrupt with its non-structural proteins (NS5A, for example; also depicted on the image above).

It was discovered that non-responders to Peg-interferon + Ribavirin have higher basal levels of ISG activity.  Hepatic Kupfer cells (resident macrophages) may play a role in the innate activation of ISG and interferon production.  It is this continuous innate interferon exposure that renders hepatocytes refractory to subsequent Peg-interferon exposures.

Recall from a previous lecture that the IL28B ‘CC’ genotype is associated with a more successful virologic response to therapy.  Perhaps it is not surprising, therefore, that patients with the CC genotype do not have very high basal levels of ISG.  Recognition of such pre-treatment factors and the likelihood of response is another step in the direction of personalized medicine for HCV treatment.

This entry was posted in Lecture. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s